Chongqing Pharscin Pharmaceutical Co., Ltd. (SHE:002907)

Market Cap	5.90B
Revenue (ttm)	785.37M
Net Income (ttm)	76.73M
Shares Out	417.60M
EPS (ttm)	0.18
PE Ratio	76.86
Forward PE	n/a
Dividend	0.10 (0.71%)
Ex-Dividend Date	Sep 10, 2024

Volume	8,418,778
Average Volume	7,017,444
Open	14.12
Previous Close	13.95
Day's Range	13.99 - 14.23
52-Week Range	11.26 - 16.76
Beta	-0.24
RSI	59.62
Earnings Date	Apr 25, 2025

About SHE:002907

Chongqing Pharscin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of drugs in China. The company offers tablets, powders, granules, soft capsules, powder injections, freeze-dried powders, injections, chemical raw materials, and small volume injections. It provides its products for the treatment of CNS, digestion, otolaryngology, oncology, cardiovascular, and cerebrovascular related diseases. The company was founded in 1996 and is headquartered in Chongqing, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1996
• Employees: 1,384
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002907

Financial Performance

In 2024, SHE:002907's revenue was 774.82 million, an increase of 12.04% compared to the previous year's 691.54 million. Earnings were 76.73 million, an increase of 134.66%.